prostate-report.org

Tasquinimod slows tumour growth

U.S. researchers say a multi-center drug trial has shown the blood vessel-blocking drug tasquinimod is good in slowing the progression of prostate cancer.

The scientists said tasquinimod works by halting new blood vessel development around the tumor, thereby stabilizing the disease. However, it does not make existing vasculature disappear.

The study’s conclusions were presented earlier this month in Chicago during a meeting of the American Society of Clinical Oncology.